By Lily Ford Last week, a poster was put up at a bus stop in east ... (Robinson, whose real name is Stephen Yaxley-Lennon, is ...

Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

Lily Wahinekapu added 10 points and seven rebounds and had six of her points in the first quarter for UH, which led 20-9 after the opening 10 minutes. Hawaii scored 31 points the rest of the game.

By Lily Ford The international film community is in uproar over the summoning of Iranian filmmakers Maryam Moghadam and Behtash Sanaeeha to court in their native country amid the production and ...

Here's how America's car obsession is driving us broke Eli Lilly plans at least $27 billion in new U.S. manufacturing investments NASCAR star William Byron dishes on Trump's visit to Daytona 500 ...

(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try to stave off competition from ...

Lilly's new offer of $499 per month is still higher than the $231 to $330 compounding pharmacies charge on average for their versions of Zepbound and Wegovy in the U.S., although health regulators ...

Lilly Offers Weight-Loss Drugs in Vials at a Discount to Fight Competition By Patrick Wingrove and Sriparna Roy (Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss ...

Compounding pharmacies that have been selling hundreds of thousands of doses of copies of Lilly's Zepbound and Novo's Wegovy while the medicines were in shortage are running out of time to produce ...

(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try to stave off competition from ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...